Flebogamma
Showing 1 - 4 of 4
Post-polio Syndrome Trial in Worldwide (Flebogamma 5% DIF, Placebo)
Suspended
- Post-polio Syndrome
- Flebogamma 5% DIF
- Placebo
-
Saint Louis, Missouri
- +26 more
Jan 27, 2022
COVID-19 Trial in Spain (Intravenous Immune Globulin, Standard Medical Treatment)
Completed
- COVID-19
- Intravenous Immune Globulin
- Standard Medical Treatment
-
San Sebastián De Los Reyes, Madrid, Spain
- +9 more
Mar 9, 2021
Alzheimer's Disease Trial in Spain, United States (Albumin 5%, Albumin 20%, Immunoglobulin)
Completed
- Alzheimer's Disease
- Albumin 5%
- +2 more
-
Sacramento, California
- +39 more
Jul 10, 2019
Primary Immune Deficiency Disease Trial in United States (Flebogamma 5% DIF)
Completed
- Primary Immune Deficiency Disease
- Flebogamma 5% DIF
-
St. Petersburg, Florida
- +6 more
Dec 7, 2016